Rectal Cancer Clinical Trials in Detroit, Michigan

4 studies are recruiting for rectal cancer in Detroit, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not given, is quality of…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Henry Ford Hospital, Detroit, Michigan
    Locations
    113 in total
    Run by
    Canadian Cancer Trials Group

    See if you can join NCT06205485 on ClinicalTrials.gov

  2. Efficacy and Safety of the CG-100 Intraluminal Bypass Device

    A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

    Stage
    Not phased
    Ages
    22 to 70
    Site
    Henry Ford Health System, Detroit, Michigan
    Locations
    10 in total
    Run by
    Colospan Ltd.

    See if you can join NCT04184973 on ClinicalTrials.gov

  3. Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

    The purpose of this research study is to evaluate epacadostat when given with routine radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer before routine surgery is performed to remove the tumor.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Henry Ford Cancer Institute, Detroit, Michigan
    Locations
    4 in total
    Run by
    Washington University School of Medicine

    See if you can join NCT03516708 on ClinicalTrials.gov

  4. F-Tryptophan PET/CT in Human Cancers

    Imaging procedures such as 1-(2-[18F]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Run by
    Barbara Ann Karmanos Cancer Institute

    See if you can join NCT05556473 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.